33 results
6-K
EX-10.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
22 Jan 24
Current report (foreign)
5:28pm
under the Company’s share option plans, the issuance of Ordinary Shares to employees pursuant to the Company’s equity incentive plans and pursuant
424B5
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
22 Jan 24
Prospectus supplement for primary offering
5:27pm
exercise of outstanding stock options pursuant to the 2022 Equity Incentive Plan and the 2023 Equity Incentive Plan, with a weighted average exercise … of outstanding stock options pursuant to the 2022 Equity Incentive Plan and the 2023 Equity Incentive Plan, with a weighted average exercise price
6-K
EX-99.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
12 Jan 24
Current report (foreign)
7:43am
-based Compensation
The Company adopted the 2022 Equity Incentive Plan (the "2022 Plan") on March 15, 2022 and the 2023 Equity Incentive Plan (the "2023
6-K
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
8 Dec 23
Current report (foreign)
6:03am
Incentive Plan and the United Kingdom Sub-Plan (the “Equity Incentive Plan Proposal”). The voting results were as follows:
For
Against
Abstain
6-K
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
8 Nov 23
Current report (foreign)
4:11pm
Group Ltd. fiscal year 2023 Annual General Meeting of Shareholders
99.2
Proxy Card
99.3
Virax Biolabs 2023 Equity Incentive Plan and UK Sub Plan
99.4
Form
6-K
EX-99.1
9avf 6z72g6q3mkbuj7
8 Nov 23
Current report (foreign)
4:11pm
6-K
EX-99.3
tnuzjr nu
8 Nov 23
Current report (foreign)
4:11pm
6-K
90bssnenvf5yn
31 Oct 23
Current report (foreign)
4:38pm
6-K
EX-99.1
s21qq
31 Oct 23
Current report (foreign)
4:38pm
6-K
EX-10.1
pcoarl2d99tw
1 Sep 23
Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum
7:37am
424B3
xsan1jm n83e
31 Mar 23
Prospectus supplement
4:04pm
424B3
0k2mayq
2 Dec 22
Prospectus supplement
4:17pm
F-1
i0faf7g buy9
18 Nov 22
Registration statement (foreign)
5:39pm
6-K
msoykafn
18 Nov 22
Current report (foreign)
5:20pm
6-K
EX-10.1
ex7cb7z9v12sgdej8t50
8 Nov 22
Virax Biolabs Group Limited Announces $3.8 Million Private Placement
4:56pm
20-F
00vkua1ufobih9 gmlf
12 Aug 22
Annual report (foreign)
4:20pm
6-K
EX-99.2
4pbuaf 5ne07p
26 Jul 22
Current report (foreign)
7:36am